{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:50:38Z","timestamp":1791301838487,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011319.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000}}],"reference-count":145,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011319.pub3","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:00:06Z","timestamp":1786359606000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-7939","authenticated-orcid":false,"given":"Gar-Way","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; Sunnybrook Health Sciences Centre, University of Toronto; Toronto Canada"},{"name":"Department of Otolaryngology - Head & Neck Surgery; University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-9662","authenticated-orcid":false,"given":"Julien","family":"Bernatchez","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; Sunnybrook Health Sciences Centre, University of Toronto; Toronto Canada"},{"name":"Department of Surgery, Division of Vascular Surgery; Centre d'Excellence des Maladies Vasculaires, Universit\u00e9 Laval; Qu\u00e9bec City Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4566-6127","authenticated-orcid":false,"given":"Brianne","family":"Yarranton","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; Sunnybrook Health Sciences Centre, University of Toronto; Toronto Canada"},{"name":"Department of Obstetrics and Gynecology; University of Ottawa; Ottawa Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-5556","authenticated-orcid":false,"given":"Andrew D","family":"Dueck","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; Sunnybrook Health Sciences Centre, University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-6195","authenticated-orcid":false,"given":"Dheeraj K","family":"Rajan","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology; Joint Department of Medical Imaging, University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-530X","authenticated-orcid":false,"given":"Thomas L","family":"Forbes","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; Toronto General Hospital, University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-7480","authenticated-orcid":false,"given":"Charles","family":"de Mestral","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; St. Michael's Hospital, University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4449-5734","authenticated-orcid":false,"given":"Ahmed","family":"Kayssi","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery; Sunnybrook Health Sciences Centre, University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"19","key":"10.1002\/14651858.CD011319.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jcin.2020.06.045","article-title":"Randomized controlled trial of acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty","volume":"13","author":"Liistro","year":"2020","journal-title":"JACC Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0002|cit2","unstructured":"Evaluation of the use of ACOTEC drug-eluting balloon Litos\u00ae in below-the-knee arteries to treat critical limb ischemia (ACOART-BTK) clinicaltrials.gov\/ct2\/show\/NCT02563535"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.avsg.2021.10.066","article-title":"Drug-coated balloon angioplasty versus standard uncoated balloon angioplasty for long femoropopliteal lesions: post hoc analysis of the 24-month results of the AcoArt I Study","volume":"82","author":"Jia","year":"2021","journal-title":"Annals of Vascular Surgery"},{"issue":"18","key":"10.1002\/14651858.CD011319.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0005|cit5","unstructured":"Prospective, multi-center and randomized controlled clinical study to verify effectiveness and safety of drug-eluting balloon in PTA procedure (AcoArt I Study) clinicaltrials.gov\/ct2\/show\/NCT01850056"},{"issue":"3","key":"10.1002\/14651858.CD011319.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1708538120953663","article-title":"Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: an additional analysis from the AcoArt I study","volume":"29","author":"Sun","year":"2020","journal-title":"Vascular"},{"issue":"23","key":"10.1002\/14651858.CD011319.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.jcin.2018.07.041","article-title":"Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of 200 Chinese patients with severe femoropopliteal lesions: 24-month results of AcoArt I","volume":"11","author":"Xu","year":"2018","journal-title":"JACC Cardiovascular Interventions"},{"issue":"3","key":"10.1002\/14651858.CD011319.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jvs.2021.01.041","article-title":"Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial","volume":"74","author":"Xu","year":"2021","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/1526602820969681","article-title":"Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of infrapopliteal artery lesions (AcoArt II-BTK)","volume":"28","author":"Jia","year":"2021","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0010|cit10","unstructured":"AcoArt\/BTK China: drug-eluting balloon for below-the-knee angioplasty evaluation in China clinicaltrials.gov\/ct2\/show\/NCT02137577"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0011|cit11","unstructured":"Prospective, multi-center and randomized controlled clinical study to verify effectiveness and safety of drug-eluting balloon in PTA procedure of the infrapopliteal artery clinicaltrials.gov\/ct2\/show\/NCT02137577"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0012|cit12","unstructured":"A prospective, multi-centre, randomized controlled, first in man study to assess the safety and performance of the Passeo-18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P-I) clinicaltrials.gov\/ct2\/show\/NCT01221610"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0014|cit14","unstructured":"Tepe G Schulte KL Zeller T Lammer J Pfaffinger P Schmidt A Six-month results of the BIOLUX P-I first in man study comparing a paclitaxel-releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions Cardiovascular and Interventional Radiology 2012 35 S264 5"},{"issue":"Suppl 84","key":"10.1002\/14651858.CD011319.pub3-BIB0015|cit15","first-page":"FV 9.7","article-title":"Twelve-month results of the BIOLUX P-I first-in-man study comparing a paclitaxel-releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions","volume":"42","author":"Zeller","year":"2013","journal-title":"VASA - Journal of Vascular Diseases"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Deloose K Zeller T Scheinert D Beschorner U BIOLUX P-II: a randomized clinical trial of Passeo-18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions Journal of the American College of Cardiology 2014 64 Suppl B","DOI":"10.1016\/j.jacc.2014.07.315"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0017|cit17","unstructured":"BIOTONIK's - first in men study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P-II) clinicaltrials.gov\/ct2\/show\/NCT01867736"},{"issue":"11 Suppl 1","key":"10.1002\/14651858.CD011319.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"B79","DOI":"10.1016\/j.jacc.2014.07.315","article-title":"BIOLUX P-II: a randomized clinical trial of Passeo-18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions","volume":"64","author":"Scheinert","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"23","key":"10.1002\/14651858.CD011319.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.jcin.2018.07.029","article-title":"Clinical randomized trial evaluating novel, microcrystalline, and biocompatible polymer paclitaxel-coated balloon for the treatment of femoropopliteal occlusive disease: The BIOPAC Trial","volume":"11","author":"Buszman","year":"2018","journal-title":"JACC Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0020|cit20","unstructured":"Prospective, pivotal, first-in-man clinical trial of the safety and efficacy of a novel microcrystalline paclitaxel coated balloon for treatment of femoropopliteal artery disease clinicaltrials.gov\/ct2\/show\/NCT02145065"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/1358863X20988360","article-title":"Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: three-year outcomes of the randomized BIOPAC trial","volume":"26","author":"Nowakowski","year":"2021","journal-title":"Vascular Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011319.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-year clinical outcomes of the CONSEQUENT trial: can femoropopliteal lesions be treated with sustainable clinical results that are economically sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0023|cit23","unstructured":"Clinical trial on peripheral arteries treated with SeQuent\u00ae please P paclitaxel coated balloon catheter (ConSeQuent) clinicaltrials.gov\/ct2\/show\/NCT01970579"},{"issue":"10","key":"10.1002\/14651858.CD011319.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00270-017-1713-2","article-title":"Angiographic and clinical outcomes after treatment of femoro-popliteal lesions with a novel paclitaxel-matrix-coated balloon catheter","volume":"40","author":"Tepe","year":"2017","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00270-022-03104-3","article-title":"Drug-eluting balloon for below the knee angioplasty: five-year outcome of the DEBATE-BTK randomized clinical trial","volume":"45","author":"Liistro","year":"2022","journal-title":"CardioVascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0027|cit27","unstructured":"Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation (DEBATE-BTK) clinicaltrials.gov\/ct2\/show\/NCT01558505"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1583\/JEVT-12-3926MR.1","article-title":"Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial","volume":"19","author":"Fanelli","year":"2012","journal-title":"Journal of Endovascular Therapy"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub3-BIB0029|cit29","first-page":"207","article-title":"The \"DEBELLUM\" - lower limb multilevel treatment with drug eluting balloon - randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"Journal of Cardiovascular Surgery"},{"issue":"13","key":"10.1002\/14651858.CD011319.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"e14840","DOI":"10.1097\/md.0000000000014840","article-title":"Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics","volume":"98","author":"Du","year":"2019","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0031|cit31","unstructured":"Effectiveness of paclitaxel-coated Luminor\u00ae balloon catheter versus uncoated balloon catheter in the arteria femoralis superficialis (EffPac) clinicaltrials.gov\/ct2\/show\/NCT02540018"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13063-016-1657-x","article-title":"The effectiveness of the paclitaxel-coated Luminor\u00ae balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial","volume":"17","author":"Teichgr\u00e4ber","year":"2016","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1148\/radiol.2020191619","article-title":"Drug-coated balloon angioplasty of femoropopliteal lesions maintained superior efficacy over conventional balloon: 2-year results of the randomized EffPac trial","volume":"295","author":"Teichgr\u00e4ber","year":"2020","journal-title":"Radiology"},{"issue":"18","key":"10.1002\/14651858.CD011319.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"e1633","DOI":"10.4244\/EIJ-D-19-00292","article-title":"Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial","volume":"15","author":"Teichgr\u00e4ber","year":"2020","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1002\/14651858.CD011319.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1148\/radiol.2020201370","article-title":"Two-year review on mortality and morbidity after femoropopliteal drug-coated balloon angioplasty in the randomized EffPac trial","volume":"296","author":"Teichgr\u00e4ber","year":"2020","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s00270-022-03265-1","article-title":"Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : 5-year results of the randomized controlled EffPac trial","volume":"45","author":"Teichgr\u00e4ber","year":"2022","journal-title":"CardioVascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0037|cit37","unstructured":"Teichgr\u00e4ber U Phase III multicenter randomized controlled trial to assess the effectiveness of paclitaxel-coated Luminor balloon catheter versus uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion Presented at the Leipzig Interventional Course; Leipzig, Germany"},{"issue":"13","key":"10.1002\/14651858.CD011319.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jcis.JCIS_34_17","article-title":"One year primary patency of infrapopliteal angioplasty using drug-eluting balloons: single center experience at King Hussein Medical Center","volume":"7","author":"Haddad","year":"2017","journal-title":"Journal of Clinical Imaging Science"},{"issue":"23","key":"10.1002\/14651858.CD011319.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jcin.2018.08.034","article-title":"Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European randomized clinical trial 2-year results","volume":"11","author":"Brodmann","year":"2018","journal-title":"JACC Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0041|cit41","unstructured":"Prospective, randomized, multi-center, single-blinded study for the treatment of subjects presenting with de novo occluded\/stenotic or re-occluded\/restenotic lesions of the superficial femoral or popliteal arteries using paclitaxel or bare percutaneous transluminal angioplasty balloon catheter clinicaltrials.gov\/ct2\/show\/NCT01858363"},{"issue":"23","key":"10.1002\/14651858.CD011319.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.116.026493","article-title":"Low-dose paclitaxel-coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease: one-year results of the ILLUMENATE European randomized clinical trial (randomized trial of a novel paclitaxel-coated percutaneous angioplasty balloon)","volume":"135","author":"Schroeder","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD011319.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/15266028211068769","article-title":"No mortality signal with stellarex low-dose paclitaxel DCB: ILLUMENATE pivotal 4-year outcomes","volume":"29","author":"Lyden","year":"2022","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0045|cit45","unstructured":"Pivotal trial of a novel paclitaxel-coated percutaneous angioplasty balloon (ILLUMENATE) clinicaltrials.gov\/ct2\/show\/NCT01858428"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.23736\/S0021-9509.16.09685-3","article-title":"Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial","volume":"58","author":"Debing","year":"2017","journal-title":"Journal of Cardiovascular Surgery"},{"issue":"17","key":"10.1002\/14651858.CD011319.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e1445","DOI":"10.4244\/eij-d-21-00444","article-title":"Paclitaxel-coated balloons versus percutaneous transluminal angioplasty for infrapopliteal chronic total occlusions: the IN.PACT BTK randomised trial","volume":"17","author":"Liistro","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0048|cit48","unstructured":"Study of IN.PACT Amphirion\u2122 drug eluting balloon vs. standard PTA for the treatment of below the knee critical limb ischemia (INPACT-DEEP) clinicaltrials.gov\/ct2\/show\/NCT00941733"},{"issue":"15","key":"10.1002\/14651858.CD011319.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1745-6215-15-63","article-title":"IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial","volume":"15","author":"Zeller","year":"2014","journal-title":"Trials"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcin.2019.10.059","article-title":"The IN.PACT DEEP clinical drug-coated balloon trial: 5-year outcomes","volume":"13","author":"Zeller","year":"2020","journal-title":"JACC Cardiovascular Interventions"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0052|cit52","first-page":"e007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"21","key":"10.1002\/14651858.CD011319.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0054|cit54","unstructured":"Randomized trial of IN.PACT Admiral\u00ae drug coated balloon vs standard PTA for the treatment of SFA and proximal popliteal arterial disease (INPACT SFA I) clinicaltrials.gov\/ct2\/show\/NCT01175850"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0055|cit55","first-page":"e005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0057|cit57","unstructured":"Moxy drug coated balloon vs. standard balloon angioplasty for the treatment of femoropopliteal arteries (LEVANT 2) clinicaltrials.gov\/ct2\/show\/NCT01412541"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovascular Interventions"},{"issue":"3","key":"10.1002\/14651858.CD011319.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/17085381211013968","article-title":"Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial","volume":"30","author":"Liao","year":"2022","journal-title":"Vascular"},{"issue":"8","key":"10.1002\/14651858.CD011319.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.25270\/jic\/19.3108.205","article-title":"Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the Lutonix BTK trial","volume":"31","author":"Mustapha","year":"2019","journal-title":"Journal of Invasive Cardiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0062|cit62","unstructured":"A prospective, multicenter, single blind, randomized, controlled trial comparing the Lutonix drug coated balloon versus standard balloon angioplasty for treatment of below-the-knee (BTK) arteries (Lutonix BTK trial) clinicaltrials.gov\/ct2\/show\/NCT01870401"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ccd.28048","article-title":"Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial","volume":"93","author":"Iida","year":"2019","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0065|cit65","unstructured":"Randomized trial of MDT-2113 drug-eluting balloon (DEB) vs. standard PTA for the treatment of atherosclerotic lesions in the superficial femoral artery and\/or proximal popliteal artery clinicaltrials.gov\/ct2\/show\/NCT01947478"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"821672","DOI":"10.3389\/fcvm.2022.821672","article-title":"A multicenter randomized trial assessing ZENFlow carrier-free drug-coated balloon for the treatment of femoropopliteal artery lesions","volume":"9","author":"Ni","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0068|cit68","unstructured":"Paclitaxel-coated balloons in femoral indication to defeat restenosis (PACIFIER) clinicaltrials.gov\/ct2\/show\/NCT01083030"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"10","key":"10.1002\/14651858.CD011319.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","article-title":"1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon","volume":"14","author":"Sachar","year":"2021","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/1358863X221097164","article-title":"The RANGER II superficial femoral artery trial: 1-year results of the long lesion cohort","volume":"27","author":"Schro\u00eb","year":"2022","journal-title":"Vascular Medicine"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s00380-021-01947-3","article-title":"One\u2011year results for Japanese patients in RANGER II SFA","volume":"37","author":"Soga","year":"2021","journal-title":"Heart and Vessels"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1526602817710770","article-title":"Six-month results from the initial randomized study of the Ranger paclitaxel-coated balloon in the femoropopliteal segment","volume":"24","author":"Bausback","year":"2017","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0074|cit74","unstructured":"Prospective, randomized, multicentre clinical study of the Hemoteq Ranger\u2122 paclitaxel-coated PTA balloon catheter (Ranger DCB) in comparison to uncoated PTA balloons in femoropopliteal lesions clinicaltrials.gov\/ct2\/show\/NCT02013193"},{"issue":"10","key":"10.1002\/14651858.CD011319.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcin.2018.01.276","article-title":"12-month results from the first-in-human randomized study of the ranger paclitaxel-coated balloon for femoropopliteal treatment","volume":"11","author":"Steiner","year":"2018","journal-title":"JACC Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0076|cit76","unstructured":"Singapore infra-genicular angioplasty with paclitaxel-eluting balloon for critical limb ischaemia (SINGA-PACLI) trial clinicaltrials.gov\/ct2\/show\/NCT02129634"},{"issue":"3","key":"10.1002\/14651858.CD011319.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1148\/radiol.2021204294","article-title":"Randomized controlled trial comparing drug-coated balloon angioplasty versus conventional balloon angioplasty for treating below-the-knee arteries in critical limb ischemia: the SINGA-PACLI trial","volume":"300","author":"Patel","year":"2021","journal-title":"Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0078|cit78","unstructured":"Tan Z Tan H Zhuang K Patel A Pua U Win H Risk of death and major amputation at 2 years in a randomized trial comparing drug coated balloon angioplasty versus conventional balloon angioplasty for treating below the knee arteries in chronic limb threatening ischemia: the SINGA-PACLI trial CardioVascular and Interventional Radiology: CIRSE 2022 Barcelona, Spain Cardiovascular and Interventional Radiological Society of Europe 2022 145 1035 10.1007\/s00270-022-03246-4"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"7","key":"10.1002\/14651858.CD011319.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijcard.2020.10.060","article-title":"Reewarm\u2122 PTX drug-coated balloon in the treatment of femoropopliteal artery disease: a multi-center, randomized controlled trial in China","volume":"326","author":"Ye","year":"2021","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0082|cit82","unstructured":"Cotavance\u2122 paclitaxel-coated balloon versus uncoated balloon angioplasty for treatment of in-stent restenosis in SFA and popliteal arteries COPA CABANA Study clinicaltrials.gov\/ct2\/show\/NCT01594684"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/13-4420R.1","article-title":"Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study","volume":"21","author":"Liistro","year":"2014","journal-title":"Journal of Endovascular Therapy"},{"issue":"12","key":"10.1002\/14651858.CD011319.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)","volume":"6","author":"Liistro","year":"2013","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0085|cit85","unstructured":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosIs and maintain vessel patency: a pilot study of anti-restenosis treatment clinicaltrials.gov\/ct2\/show\/NCT01366482"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0086|cit86","unstructured":"European study of POBA versus Cotavance paclitaxel coated balloon for the treatment of infrapopliteal lesions in critical limb ischemia clinicaltrials.gov\/ct2\/show\/NCT01260870"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0087|cit87","unstructured":"Femoral artery in-stent restenosis (FAIR) trial clinicaltrials.gov\/ct2\/show\/record\/NCT01305070"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0088|cit88","unstructured":"Tacke J Kieselbach D Schulte KL The Freeway stent study Presented at the Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C."},{"issue":"9","key":"10.1002\/14651858.CD011319.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0090|cit90","unstructured":"Randomized trial of paclitaxel eluting balloon or conventional balloon for treatment of in-stent restenosis of the superficial femoral artery in patients with symptomatic peripheral artery disease (ISAR-PEBIS) clinicaltrials.gov\/ct2\/show\/NCT01083394"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0091|cit91","unstructured":"Randomized trial of stenting after dilation with or without paclitaxel eluting balloon or atherectomy in patients with symptomatic peripheral artery disease clinicaltrials.gov\/ct2\/show\/NCT00986752"},{"issue":"9","key":"10.1002\/14651858.CD011319.pub3-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1590\/1806-9282.20210156","article-title":"Comparison of standard balloon and drug-coated balloon angioplasty in patients with the below-the-knee peripheral artery disease","volume":"67","author":"Kaygin","year":"2021","journal-title":"Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0093|cit93","unstructured":"A monocenter randomized clinical trial of PAClitaxel drUg-eluting BAlloon versus standard percutaneous transluminal angioplasty to reduce restenosis in patients with in-stent stenoses in the superficial femoral and proximal popliteal artery clinicaltrials.gov\/ct2\/show\/NCT01247402"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0094|cit94","unstructured":"Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions clinicaltrials.gov\/ct2\/show\/NCT01298947"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1745-6215-14-87","article-title":"Randomized trial of Legflow\u00ae paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial","volume":"14","author":"Karimi","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0096|cit96","unstructured":"Swedish drug-elution trial in peripheral arterial disease - a multicenter, prospective randomized controlled clinical trial based on the Swedish Vascular Registry (SWEDVASC) Platform clinicaltrials.gov\/ct2\/show\/NCT02051088"},{"issue":"10","key":"10.1002\/14651858.CD011319.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.carrev.2020.03.030","article-title":"Comparative 12-month outcomes of drug-coated balloon versus non-drug-coated balloon revascularization strategy in chronic limb-threatening ischemia: results from the XLPAD registry","volume":"21","author":"Giannopoulos","year":"2020","journal-title":"Cardiovascular Revascularization Medicine"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0098|cit98","unstructured":"Paclitaxel coated balloons for prevention of restenosis in small arteries below the knee compared to angioplasty using uncoated balloons clinicaltrials.gov\/ct2\/show\/NCT00696956"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0099|cit99","unstructured":"Advance\u00ae 18PTX\u00ae balloon catheter study: treatment of lesions in superficial femoral artery\/popliteal artery with a paclitaxel-coated balloon clinicaltrials.gov\/ct2\/show\/NCT00776906"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0100|cit100","unstructured":"A prospective, multicenter, single blind, randomized, controlled Japanese population trial comparing MD02-LDCB versus standard balloon angioplasty for treatment of femoropopliteal arteries clinicaltrials.gov\/ct2\/show\/NCT01816412"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0101|cit101","unstructured":"Phase III FREERIDE study freeway randomized angioplasty study clinicaltrials.gov\/ct2\/show\/NCT01960647"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0102|cit102","first-page":"S50","article-title":"SELUTION4BTK \u2013 a randomized clinical trial evaluating selution SLR sirolimus-eluting balloon in the treatment of below-the-knee lesions in patients with chronic limb-threatening ischemia","volume":"16","author":"Armstrong","year":"2023","journal-title":"JACC: Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-022-06242-8","article-title":"Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the \u201cSirPAD\u201d randomized controlled trial","volume":"23","author":"Barco","year":"2022","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1024\/0301-1526\/a000973","article-title":"Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: the SirPAD randomized trial","volume":"50","author":"Barco","year":"2021","journal-title":"VASA - European Journal of Vascular Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jvir.2014.12.013","article-title":"Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease","volume":"26","author":"Baerlocher","year":"2015","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"9501","key":"10.1002\/14651858.CD011319.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"issue":"10390","key":"10.1002\/14651858.CD011319.pub3-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","article-title":"A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"issue":"25","key":"10.1002\/14651858.CD011319.pub3-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD011319.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.jvs.2010.02.002","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial in perspective","volume":"51","author":"Bradbury","year":"2010","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jvs.2014.03.235","article-title":"Infrainguinal angioplasty with drug-eluting stents and balloons","volume":"59","author":"Canaud","year":"2014","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub3-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jvs.2023.05.042","article-title":"Apples and oranges? A comparison of BEST-CLI to BASIL-2","volume":"78","author":"Conte","year":"2023","journal-title":"Journal of Vascular Surgery"},{"issue":"9","key":"10.1002\/14651858.CD011319.pub3-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejvs.2024.10.009","article-title":"Editor's Choice\u2013European Journal of Vascular and Endovascular Surgery publication standards for reporting vascular surgical research","volume":"69","author":"Borst","year":"2025","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0116|cit116","unstructured":"UPDATE: Paclitaxel-coated devices to treat peripheral arterial disease unlikely to increase risk of mortality - letter to health care providers https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.avsg.2024.12.009","article-title":"Rate and predictors of disease progression in patients with conservatively managed intermittent claudication: a systematic review","volume":"112","author":"Froud","year":"2024","journal-title":"Annals of Vascular Surgery"},{"issue":"14","key":"10.1002\/14651858.CD011319.pub3-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001329","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Gornik","year":"2025","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0119|cit119","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0120|cit120","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"11","key":"10.1002\/14651858.CD011319.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic)","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejvs.2014.02.011","article-title":"Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 1: above the knee)","volume":"47","author":"Jens","year":"2014","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejvs.2014.02.012","article-title":"Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 2: below the knee)","volume":"47","author":"Jens","year":"2014","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"3","key":"10.1002\/14651858.CD011319.pub3-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.1016\/j.jvs.2021.06.115","article-title":"Predictors of amputation-free survival after endovascular intervention for chronic limb-threatening ischemia","volume":"74","author":"Joshi","year":"2021","journal-title":"Journal of Vascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1136\/bmjopen-2016-011245","article-title":"Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK","volume":"6","author":"Katsanos","year":"2016","journal-title":"BMJ Open"},{"issue":"24","key":"10.1002\/14651858.CD011319.pub3-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/jaha.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jvir.2021.03.537","article-title":"The rollercoaster of paclitaxel in the lower limbs and skeletons in the closet: an opinion review","volume":"32","author":"Katsanos","year":"2021","journal-title":"Journal of Vascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0129|cit129","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-0038-1676360","article-title":"Drug-eluting balloons and drug-eluting stents in the treatment of peripheral vascular disease","volume":"35","author":"Lindquist","year":"2018","journal-title":"Seminars in Interventional Radiology"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1056\/nejmcp2501200","article-title":"Peripheral artery disease in the legs","volume":"394","author":"McDermott","year":"2026","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","article-title":"Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry","volume":"5","author":"Micari","year":"2012","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0133|cit133","first-page":"S5","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"TASC II Working Group","journal-title":"Journal of Vascular Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub3-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ccd.25536","article-title":"Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany","volume":"84","author":"Pietzsch","year":"2014","journal-title":"Catheterization & Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00270-021-03050-6","article-title":"Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease in the Netherlands and Germany","volume":"45","author":"Pietzsch","year":"2022","journal-title":"CardioVascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0136|cit136","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2022"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub3-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"e012074","DOI":"10.1161\/CIRCINTERVENTIONS.122.012074","article-title":"Update from the longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries: The SAFE-PAD Study","volume":"15","author":"Secemsky","year":"2022","journal-title":"Circulation: Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jacc.2011.05.034","article-title":"First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome","volume":"58","author":"Schmidt","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/erd.12.67","article-title":"Drug-coated balloons and their place in treating peripheral arterial disease","volume":"10","author":"Schnorr","year":"2013","journal-title":"Expert Review of Medical Devices"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jvs.2012.12.069","article-title":"Local drug delivery to prevent restenosis","volume":"57","author":"Seedial","year":"2013","journal-title":"Journal of Vascular Surgery"},{"issue":"26","key":"10.1002\/14651858.CD011319.pub3-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1056\/NEJMoa2005206","article-title":"Mortality with Paclitaxel-coated devices in peripheral artery disease","volume":"383","author":"Nordanstig","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"10508","key":"10.1002\/14651858.CD011319.pub3-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(25)01584-3","article-title":"Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial","volume":"406","author":"Nordanstig","year":"2025","journal-title":"Lancet"},{"issue":"21","key":"10.1002\/14651858.CD011319.pub3-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD011319.pub3-BIB0144|cit144","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011319","article-title":"Drug-eluting balloon angioplasty versus non-stenting balloon angioplasty for peripheral arterial disease of the lower limbs","author":"Kayssi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011319.pub3-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011319.pub2","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","author":"Kayssi","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:50:51Z","timestamp":1791298251000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011319.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":145,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011319.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}